Collaborate with others to discuss how to implementation strategies for DRA compliance, HHS and OIG describing lessons learned from current litigations, updated information by NACDS detailing the AMP litigation, organized dispute resolution meetings facilitated by CMS, and more.
By registering to be a member of the Medicaid Drug Rebate Program group, you consent to have your name and your email address be accessible by the official representative of the Medicaid Drug Rebate Program group, and to be identified as a Medicaid Drug Rebate Program group member in your profile and the LinkedIn search results. If you do not wish to give such consent, please do not register.
Not a user? You may have been sent a link that is only for our users. Joining LinkedIn takes just a moment.